title: [Current status of the study of genetic engineering in the hematology].
authors.forename: A
authors.initials: A
authors.lastname: Shibata
authors.forename: K
authors.initials: K
authors.lastname: Kishi
authors.forename: S
authors.initials: S
authors.lastname: Koyama
authors.forename: K
authors.initials: K
authors.lastname: Nagai
authors.forename: S
authors.initials: S
authors.lastname: Aoki
authors.forename: H
authors.initials: H
authors.lastname: Saito
authors.forename: W
authors.initials: W
authors.lastname: Tatewaki
authors.forename: K
authors.initials: K
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Furukawa
mesh_terms: D001688:Biological Products / Q000627:therapeutic use*; D017977:Deltaretrovirus / Q000235:genetics; D004921:Erythropoietin / Q000627:therapeutic use; D005818:Genetic Engineering; D006678:HIV / Q000235:genetics; D006402:Hematologic Diseases / Q000235:genetics* / Q000628:therapy; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics*; D007938:Leukemia / Q000235:genetics; D008223:Lymphoma / Q000235:genetics; D009857:Oncogenes; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D014162:Transfection; D014178:Translocation, Genetic
chemical_list: D001688:Biological Products; D007136:Immunoglobulins; D011948:Receptors, Antigen, T-Cell; D004921:Erythropoietin